The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...

The late Dr. David Ahlquist co-invented ColoGuard, which is helping drive Abbott Laboratories’ acquisition of Exact Sciences. After an ALS diagnosis in 2019, Ahlquist wasn’t done inventing.

Jadeja's spin magic guided India to a dominant 337-run victory over South Africa in the 2015 Delhi Test, clinching the series ...

About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose readings.

A high-level delegation from Abbott, led by the company’s Divisional Vice President for EMEA & Global Accounts, has paid a ...

Grail Inc. is downgraded from Speculative Buy to Hold after a rapid share price surge from $55 to $100. Click here to read my ...

His 82 against English Test quicks Matthew Potts and Josh Tongue in Canberra followed the cauldron of Mitchell Starc and Josh Hazlewood on a tricky SCG wicket. Kellaway did what only one Englishman ...

Pat Cummins is firming to return from his back injury for the second Ashes Test after getting through another lengthy bowling ...

The global lateral flow assays market size is expected to reach USD 17.44 billion by 2033, registering a CAGR of 6.98% from 2025 to ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...

Abbott said on Thursday it would buy cancer test maker Exact Sciences in a deal valued at up to $23 billion, including debt, marking one of its largest acquisitions in nearly a decade and its first ...